Premium
Increase of immunoglobulin A during ibrutinib therapy reduces infection rate in chronic lymphocytic leukemia patients
Author(s) -
Cassin Ramona,
Visentin Andrea,
Giannarelli Diana,
Noto Alessandro,
Mauro Francesca Romana,
Baldini Luca,
Trentin Livio,
Reda Gianluigi
Publication year - 2021
Publication title -
hematological oncology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.918
H-Index - 44
eISSN - 1099-1069
pISSN - 0278-0232
DOI - 10.1002/hon.2814
Subject(s) - ibrutinib , chronic lymphocytic leukemia , medicine , immunology , leukemia
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom